Biomarkers and Mortality in Severe Chagas Cardiomyopathy

Simple item page
dc.contributor.authorJacqueline E. Sherbuk
dc.contributor.authorEmi Okamoto
dc.contributor.authorMorgan A. Marks
dc.contributor.authorEnzo Fortuny
dc.contributor.authorEva H. Clark
dc.contributor.authorGerson Galdos‐Cardenas
dc.contributor.authorAngel Vasquez-Villar
dc.contributor.authorAntonio B. Fernández
dc.contributor.authorThomas Crawford
dc.contributor.authorQ. Rose
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:09:52Z
dc.date.available2026-03-22T14:09:52Z
dc.date.issued2015
dc.descriptionCitaciones: 38
dc.description.abstractSevere Chagas cardiomyopathy is associated with high short-term mortality. BNP, NT-proBNP, CK-MB, and MMP-2 have added predictive value for mortality, even in the presence of decreased ejection fraction and other clinical signs of congestive heart failure.
dc.identifier.doi10.1016/j.gheart.2015.07.003
dc.identifier.urihttps://doi.org/10.1016/j.gheart.2015.07.003
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44914
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofGlobal Heart
dc.sourceYale New Haven Hospital
dc.subjectMedicine
dc.subjectChecklist
dc.subjectGlobal health
dc.subjectObservational study
dc.subjectStrengthening the reporting of observational studies in epidemiology
dc.subjectEpidemiology
dc.subjectFamily medicine
dc.subjectPublic health
dc.subjectMedical education
dc.titleBiomarkers and Mortality in Severe Chagas Cardiomyopathy
dc.typearticle

Files

Collections

Artículo Científico Publicado